Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report

CVIR Endovascular

Shivendra Lalloo¹  Dylan Kurda¹  Geetha Guduguntla¹  Julian Maingard²  Hong Kuan Kok³ 

[1] 0000 0000 9984 5644, grid.413314.0, Interventional Radiology, The Canberra Hospital, Canberra, Australia;grid.410678.c, Interventional Radiology, Austin Health, Melbourne, VIC, Australia;0000 0001 0526 7079, grid.1021.2, School of Medicine, Deakin University, Waurn Ponds, Geelong, Australia;grid.410684.f, Interventional Radiology, Northern Health, Melbourne, VIC, Australia;0000 0001 0526 7079, grid.1021.2, School of Medicine, Deakin University, Waurn Ponds, Geelong, Australia;

关键词: Embolization;    PHIL;    Uterine artery;    AVM;   

DOI  :  10.1186/s42155-019-0059-z

来源: publisher

【 摘 要 】

ObjectiveUterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent.Case reportA 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient’s menstrual cycle was restored 8 weeks after the procedure.ConclusionUterine AVM can be treated safely and effectively with UAE using PHIL.

【 授权许可】

CC BY